Duplicate_SCRI - Tennessee Oncology /ID# 269921 — Nashville, Tennessee

Duplicate_SCRI - Tennessee Oncology /ID# 269921 is a clinical research site located in Nashville, Tennessee, United States 37203-1632.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Duplicate_SCRI - Tennessee Oncology /ID# 269921 has participated in 1 clinical trials.

Therapeutic areas: Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duplicate_SCRI - Tennessee Oncology /ID# 269921?

Duplicate_SCRI - Tennessee Oncology /ID# 269921 has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duplicate_SCRI - Tennessee Oncology /ID# 269921 conducted?

Duplicate_SCRI - Tennessee Oncology /ID# 269921 has 1 clinical trials on record. Their work covers Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer.

Is Duplicate_SCRI - Tennessee Oncology /ID# 269921 accredited by Crixeo Health?

Duplicate_SCRI - Tennessee Oncology /ID# 269921 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duplicate_SCRI - Tennessee Oncology /ID# 269921?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.